GHTF consults on guidance for reporting adverse events during pre-market clinical investigations
This article was originally published in Clinica
Executive Summary
The Global Harmonization Task Force is seeking stakeholder feedback on a new guidance document on reporting adverse events during pre-market clinical investigations of medical devices. Comments will be accepted until 10 December.